Další formáty:
BibTeX
LaTeX
RIS
@misc{2243544, author = {Bacci, Sabrina and Nicolay, Nathalie}, keywords = {Technical Report; COVID-19; SARI}, language = {eng}, publisher = {FNUSA, ECDC}, title = {Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to SARS-CoV-2 in individuals aged 20 years and older – third update}, url = {https://www.ecdc.europa.eu/sites/default/files/documents/Interim-analysis-COVID-19-vaccine-over-20.pdf}, year = {2022} }
TY - JFULL ID - 2243544 AU - Bacci, Sabrina - Nicolay, Nathalie PY - 2022 TI - Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to SARS-CoV-2 in individuals aged 20 years and older – third update PB - FNUSA, ECDC KW - Technical Report KW - COVID-19 KW - SARI UR - https://www.ecdc.europa.eu/sites/default/files/documents/Interim-analysis-COVID-19-vaccine-over-20.pdf N2 - This current report builds on previous analyses [3,4,5] and extends the age groups included. An overview of outcomes, study period and age groups included in the analysis are presented in Table 1 Previous ECDC publications on COVID-19 vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection laboratory-confirmed with SARS-CoV-2, are available [3,4]. This third update contains vaccine effectiveness results among individuals aged 20 years and older for the Omicron period) for the first time as well as estimates by COVID-19 vaccine product (i.e. Comirnaty and Vaxzevria). ER -
BACCI, Sabrina a Nathalie NICOLAY. \textit{Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to SARS-CoV-2 in individuals aged 20 years and older – third update}. FNUSA, ECDC, 2022.
|